Midwest - The START Center for Cancer Research
Oncology • Grand Rapids, MI • 1 (Grand Rapids, MI) locations
About
Summary: - The START Center for Cancer Research (START) is a biotechnology contract research organization with multiple locations, including START Midwest in Grand Rapids, Michigan. - Key activities include early-phase clinical trials (Phase 1/1b) for cancer therapies, collaborations with sponsors like AbbVie and MonTa Biosciences, and ongoing patient dosing in studies such as ABBV-438 for multiple myeloma and MBS8 studies in Madrid (Madrid reference appears in milestones but not directly in Grand Rapids). - The Grand Rapids site is one of START’s 11 offices worldwide, contributing to the organization’s 4-country footprint and 221 employees (as of the latest data). - Recent milestones (notable for Midwest/Grand Rapids context) include patient dosing in related START centers and publications by START investigators, underscoring active trial activity across the Midwest network. If you’re specifically researching START Midwest in Grand Rapids, you may want to look for: - Local trial listings or contact details for the Grand Rapids site. - Current Phase 1/1b studies recruiting at START Midwest. - Links to press releases or investor updates mentioning Grand Rapids milestones.
Clinic Type
Oncology
Address
5800 Foremost Dr SE, Grand Rapids, MI 49546
Phone
+1 (616) 954-5554
information@startresearch.com
Opening Hours
Monday - Friday | 8am - 5pm EST
Services Offered
—
Team
Insurance & Payment
—
Languages Spoken
—
Social Media
Photos








What Patients Say
Overall sentiment across review platforms: mixed
- Indeed.com profile for The START Center for Cancer Research: 4.0 out of 5 stars (5 reviews for the research organization specifically (though aggregated review pages contain many more mixed employee reviews))
Patients praise
- Patients report appreciation for access to clinical trials locally in West Michigan
- Some employees enjoy the mission of helping patients and find colleagues to be supportive
- Collaborative approach with patients' primary oncologists and healthcare systems
Common complaints
- Work environment described as toxic by some employees
- Reports of micromanagement and poor supervisory communication
- High turnover rate and concerns about fair workload distribution
"What is the part of working at the company? Helping patients stay in a positive mood."
— Indeed employee review"I decided to take a chance at START Midwest to see if there’s another option to treat her cancer. [Contributing] to research is another reason why she wanted to participate in the studies at START Midwest."
— Clinical trial patient interview reported by WWMT newsSynthesized from public review platforms as of Jul 11, 2026 — sources: [1][2][3][4].
In the News
- Trinity Health Grand Rapids announces $22.7 million investment into Richard J. Lacks Sr. Cancer Center | Trinity Health Michigan — May 6, 2026
- Michael J. Wick, PhD - The START Center for Cancer Research — Sep 2, 2025
- Trinity Health plans $22.7M in upgrades to Lacks Cancer Center | WOODTV.com — May 6, 2026
- Trinity Health Grand Rapids First Cancer Center in Michigan to Offer New Image-Guided, Non-Invasive Radiation Therapy | Trinity Health Michigan — Oct 28, 2025
- Helen DeVos Children's Hospital leads research of radiopharmaceuticals, an emerging form of cancer therapy in West Michigan — Oct 23, 2025
Information sourced from the clinic's website as of July 11, 2026.
More oncology clinics in Grand Rapids
Corewell Health is a nonprofit, large Michigan-based health system formed in 2022 by merging Beaumont Health and Spectrum Health. It is headquartered in Grand Rapids and is the state's largest healthcare system by inpatient admissions and net patient revenue, employing tens of thousands of staff. The network emphasizes accessible, affordable, equitable care with same-day options for non-life-threatening conditions and operates across a connected system, including several international locations. For Medical Oncology in Grand Rapids, Corewell Health is a primary local provider option, with physician specialists and related roles listed among its open positions and services.
The Cancer & Hematology Centers (CHC) is Michigan’s largest privately owned oncology/hematology practice, founded in 1979 and headquartered in Grand Rapids. CHC provides comprehensive, contemporary cancer care with a compassionate patient focus. It operates 8 offices across Michigan, including locations in Grand Rapids, Muskegon, and Holland, with a notable Grand Rapids presence at 145 Michigan St NE, Suite 3100. Contact options include main numbers: (800) 411-7999 and (616) 975-6149.
Comparing your options?
See other oncology clinics in Grand Rapids, or search the full directory by insurance, ratings, and more.

